DE2728271A1 - Verfahren zur markierung organischer stoffe mit technetiumisotopen - Google Patents

Verfahren zur markierung organischer stoffe mit technetiumisotopen

Info

Publication number
DE2728271A1
DE2728271A1 DE19772728271 DE2728271A DE2728271A1 DE 2728271 A1 DE2728271 A1 DE 2728271A1 DE 19772728271 DE19772728271 DE 19772728271 DE 2728271 A DE2728271 A DE 2728271A DE 2728271 A1 DE2728271 A1 DE 2728271A1
Authority
DE
Germany
Prior art keywords
radioactive
reducing agent
alkaline
technetium
cpd
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19772728271
Other languages
German (de)
English (en)
Other versions
DE2728271C2 (fi
Inventor
Rudolf Prof Dipl Chem D Muenze
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akademie der Wissenschaften der DDR
Original Assignee
Akademie der Wissenschaften der DDR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akademie der Wissenschaften der DDR filed Critical Akademie der Wissenschaften der DDR
Publication of DE2728271A1 publication Critical patent/DE2728271A1/de
Application granted granted Critical
Publication of DE2728271C2 publication Critical patent/DE2728271C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/025—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus inorganic Tc complexes or compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE19772728271 1976-07-13 1977-06-23 Verfahren zur markierung organischer stoffe mit technetiumisotopen Granted DE2728271A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DD19381676A DD127200B1 (de) 1976-07-13 1976-07-13 Verfahren zur markierung organischer stoffe mit technetiumisotopen

Publications (2)

Publication Number Publication Date
DE2728271A1 true DE2728271A1 (de) 1978-01-19
DE2728271C2 DE2728271C2 (fi) 1987-09-10

Family

ID=5505105

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772728271 Granted DE2728271A1 (de) 1976-07-13 1977-06-23 Verfahren zur markierung organischer stoffe mit technetiumisotopen

Country Status (2)

Country Link
DD (1) DD127200B1 (fi)
DE (1) DE2728271A1 (fi)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NICHTS-ERMITTELT *

Also Published As

Publication number Publication date
DD127200A1 (fi) 1977-09-14
DD127200B1 (de) 1986-06-11
DE2728271C2 (fi) 1987-09-10

Similar Documents

Publication Publication Date Title
DE3840044A1 (de) Glykosphingolipide mit kopplungsfaehiger gruppe im sphingoidanteil, ihre herstellung und verwendung
EP0108253A1 (de) Technetium-99m-Tetraphosphonate zur szintigraphischen Darstellung RES-haltiger Organe und der Lymphgefässe und Verfahren zu deren Herstellung
DE2534985C2 (fi)
DE2366614C2 (fi)
EP2849807A1 (de) Satz und verfahren zur herstellung eines radiopharmakons
DE1141639B (de) Verfahren zur Herstellung wasserloeslicher Cholinphosphorsaeure-diglyceridester-Verbindungen
DE2728271A1 (de) Verfahren zur markierung organischer stoffe mit technetiumisotopen
DE2809897C2 (de) Verfahren zur Isolierung von Coformycin und verwandter Nucleoside aus ihren Mischungen
DE2327870C2 (de) Verfahren zur Herstellung eines mit 99↑m↑ Tc markierten Phosphat-Zinn-Komplexes zur Szintigraphie
DE2625826C3 (de) Hydroxyalkylester der Tetrajodterephthalsäure, Verfahren zu deren Herstellung und diese enthaltende Röntgenkontrastmittel
EP0003041B1 (de) Technetium-99m-markiertes Diagnostikum zur Darstellung des retikuloendothelialen Systems (RES) und Verfahren zu seiner Herstellung
DE4217916C2 (de) N-Alkylamin- und N-Arylalkylaminderivate von Heparin, Verfahren zu ihrer Herstellung und ihrer Verwendung
DE1911240A1 (de) Neues Antibioticum und seine Herstellung
DE69431049T2 (de) Stickstoff-schwefel-liganden auf imidazolbasis verwendbar in radiographischen abbildungsmitteln
EP0251046B1 (de) Diagnostikum zur szintigraphischen Darstellung von bösartigen Tumoren
DE69421173T2 (de) Neue stickstoff-schwefel-liganden auf der basis eines heterocyclus für die verwendung in werkstoffen für die radiographische bildgebung
DE2920411C2 (de) Herzglykosid-Protein-Konjugat zur Gewinnung von Antikörpern für die Radioimmunbestimmung von Pengitoxin sowie eine radioaktiv markierte Testsubstanz für diese Bestimmung
DE69525647T2 (de) Inklusionskomplexe von radiohalogenierten fettsäuren in einer zyklodextrine
DE2607680C2 (fi)
EP0335296B1 (de) Tc-99m-w-Alkylphosphinico-1-hydroxyalkan-1,1-diphosphonate enthaltende Präparate zur Knochenszintigraphie sowie Verfahren zur Herstellung dieser Präparate
DE942534C (de) Verfahren zur Herstellung von haltbaren und gut wirksamen Loesungen oder Suspensionen antibiotischer Mittel
AT345482B (de) Verfahren zur herstellung von neuen insulinderivaten
EP1034797A2 (de) Verfahren zur Herstellung eines 18 F-markierten Glykosylierungsreagenz sowie 18 F-Glykosylierungsreagenz und dessen Verwendung
DD225789A1 (de) Verfahren zur verbesserung kernspintomographischer messungen biologischer objekte
Seubert et al. Side reactions in Karl-Fischer-reagents

Legal Events

Date Code Title Description
8141 Disposal/no request for examination
8110 Request for examination paragraph 44
8170 Reinstatement of the former position
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee